Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
J Immunol ; 195(9): 4438-45, 2015 Nov 01.
Article in English | MEDLINE | ID: mdl-26416278

ABSTRACT

Human ß defensin-3 (hBD-3), an epithelial cell-derived antimicrobial peptide, mediates chemotaxis and activation of myeloid cells. In this study, we provide evidence that hBD-3 induces the costimulatory molecule CD86 on primary human monocytes by a mechanism involving autocrine activation of ionotropic P2X7 receptors (P2X7R) by ATP. Incubation of monocytes with hBD-3 resulted in increased expression of both the CD80 and CD86 costimulatory molecules. Treatment of monocytes with a selective P2X7R antagonist inhibited the ability of hBD-3 to induce expression of CD86 but not CD80. The hBD-3-dependent upregulation of CD86 was also attenuated in monocytes incubated with apyrase, a potent scavenger of extracellular ATP. Finally, direct activation of monocyte P2X7R by exogenous ATP mimicked the ability of hBD-3 to induce CD86 expression. These data suggest that hBD-3 induces monocyte activation by both P2X7-dependent (CD86 upregulation) and P2X7-independent (CD80 upregulation) signaling mechanisms and raise the possibility that activation of P2X7R could play an important role in shaping the inflammatory microenvironment in conditions where hBD-3 is highly expressed, such as psoriasis or oral carcinoma.


Subject(s)
Adenosine Triphosphate/pharmacology , B7-2 Antigen/metabolism , Monocytes/drug effects , Receptors, Purinergic P2X7/metabolism , beta-Defensins/pharmacology , Apyrase/metabolism , Apyrase/pharmacology , B7-1 Antigen/genetics , B7-1 Antigen/metabolism , B7-2 Antigen/genetics , Calcium/metabolism , Cells, Cultured , Flow Cytometry , Gene Expression/drug effects , Humans , Monocytes/metabolism , Purinergic P2X Receptor Antagonists/pharmacology , Receptors, Purinergic P2X7/genetics , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Signal Transduction/genetics
2.
J Acquir Immune Defic Syndr ; 71(5): 483-92, 2016 Apr 15.
Article in English | MEDLINE | ID: mdl-26627102

ABSTRACT

BACKGROUND: HIV-infected patients who fail to normalize CD4 T cells despite suppressive antiretroviral therapy have impaired immune homeostasis: diminished naive T-cell numbers, elevated T-cell turnover, senescence, and inflammation. METHODS: Blood samples from immune failures (n = 60), immune successes (n = 20), and healthy controls (n = 20) were examined for plasma interleukin (IL)-7 levels, for cellular expression of the IL-7Rα chain (CD127), for the exhaustion and senescence markers programed death 1 (PD-1) and CD57, and for the survival factor Bcl2. Because both inflammatory and homeostatic cytokines can induce T-cell cycling, we also examined the effects of these mediators on exhaustion and senescence markers. RESULTS: Plasma levels of IL-7 were elevated and both CD4 and CD8 T-cell CD127 expression was decreased in immune failure. Plasma levels of IL-7 correlated directly with naive CD4 T-cell counts in immune success and inversely with T-cell cycling (Ki67) in healthy controls and immune success, but not in immune failure. CD4 T-cell density of PD-1 was increased and Bcl2+ CD4 T cells were decreased in immune failure but not in immune success, whereas the proportion of T cells expressing CD57 was increased in immune failure. PD-1 and CD57 were induced on CD4 but not CD8 T cells by stimulation in vitro with inflammatory IL-1ß or homeostatic (IL-7) cytokines. CONCLUSIONS: Perturbation of the IL-7/IL-7 receptor axis, increased T-cell turnover, and increased senescence may reflect dysregulated responses to both homeostatic and inflammatory cytokines in immune failure patients.


Subject(s)
HIV Infections/immunology , Interleukin-7/blood , Adult , Anti-HIV Agents , Biomarkers/metabolism , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/immunology , CD57 Antigens/metabolism , CD8-Positive T-Lymphocytes/immunology , Case-Control Studies , Cell Death/physiology , Cellular Senescence/immunology , Female , Humans , Immunophenotyping , Interleukin-7 Receptor alpha Subunit/blood , Lymphocyte Activation/immunology , Male , Treatment Failure , bcl-Associated Death Protein/blood
SELECTION OF CITATIONS
SEARCH DETAIL